Abstract
Alzheimer's disease (AD) is the most common neurodegenerative disease among the elderly, with progressive decline in cognitive function, significantly affecting quality of life. The prevalence and emotional and financial burden of AD on patients, their families and society are predicted to grow significantly in the near future due to the global increase in life expectancy at birth. Thus, …